Novartis Bioventures Ltd - Insider Stock Trading - OpenInsider

CIK: 1297709 - Address: Forum 1-1.32, Lichtstrasse 35, Basel, V8 CH-4056

10 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	6	1	6	2	3	19	28	40	54	24
P	%wins				83	50	67	67	67	50	64

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
7/2/20 16:16	6/30/20	AKUS	Akouos, Inc.	V8	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	V8	H	Former 1	P.d	2,125	17.00	0	125	12	1,181	I
11/12/19 16:15	11/12/19	GRTX	Galera Therapeutics, Inc.	V8	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	V8	T		P.d	3,000	12.00	0	250	8	3,543	I
5/30/19 21:27	5/28/19	BCYC	Bicycle Therapeutics Plc	V8	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	V8	T		P.d	2,361	14.00	0	169	11	1,770	D
7/5/17 18:05	7/5/17	ALRN	Aileron Therapeutics Inc	DE	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	V8	T		P.d	4,000	15.00	0	267	12	2,544	D
10/31/16 16:50	10/31/16	RARX	Ra Pharmaceuticals, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	V8	T		P.d	1,100	13.00	21	85	3	2,546	D									1	-1	1	24	78
4/12/16 17:09	4/12/16	AGLE	Aeglea Biotherapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	D0	T		P.d	3,000	10.00	8	300	15	2,311	D									4	1	-8	-53	-27
2/17/16 18:47	2/17/16	PTI	Proteostasis Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	D0	T		P.d	3,000	8.00	6	375	25	1,874	D									-2	13	66	119	161	170
9/24/14 17:42	9/22/14	TKAI	Tokai Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	D0	T		P.d	4,875	15.00	33	325	8	4,644	D								-14	1	-4	-15	-5	-16	-17
3/27/14 16:02	3/25/14	AKBA	Akebia Therapeutics, Inc.	DE	Health	Drug	Pharmaceutical Preparations	Novartis Bioventures Ltd	D0	T		P.d	3,104	17.00	30	183	6	3,406	D								-20	3	13	19	49	8	-48
2/6/14 15:52	2/4/14	CLDN	Celladon Corp	DE	Health	BioPrd	Biological Products, (No Diag	Novartis Bioventures Ltd	D0	T		P.d	1,299	8.00	4	162	12	1,552	D								-9	2	-2	49	31	37	109

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact